文献速递胃肠动力与功能性疾病

利用潜在类别分析推导并验证肠易激综合征诊断测试

Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.
PubMed 文献 · Aliment Pharmacol Ther · 2017-01-20

研究在加拿大1981例和英国360例因胃肠道症状转诊二级医疗的患者中,利用潜在类别分析构建并验证基于症状的肠易激综合征诊断测试。加拿大队列敏感度44.7%、特异度85.3%,英国队列敏感度52.5%、特异度84.3%。该测试准确性与基于症状的标准相当,作者提出可通过加入乳糜泻血清学和粪便钙卫蛋白等临床标志物改进。

要点

  • 基于潜在类别分析的肠易激综合征诊断测试在加拿大和英国队列中敏感度44.7%和52.5%,特异度85.3%和84.3%。
  • 加拿大队列阳性似然比3.03、阴性似然比0.65,英国队列分别为3.35和0.56。
  • 作者认为该测试准确性与基于症状的标准相当,并可通过加入临床标志物改进。

核心结论

  • 利用患者报告症状并纳入潜在类别模型的肠易激综合征诊断测试,其准确性相当于基于症状的标准。
  • 该测试有通过加入乳糜泻血清学和粪便钙卫蛋白等临床标志物进行改进的潜力。

研究设计与样本

  • 从加拿大1981例和英国360例因胃肠道症状转诊二级医疗的患者中收集症状、结肠镜和组织学数据。
  • 利用潜在类别分析在加拿大数据集中识别患者报告症状的自然聚类,并将由此得出的潜在类别模型应用于英国数据集进行验证。
  • 计算潜在类别模型的敏感度、特异度及阳性和阴性似然比。

主要发现

  • 加拿大队列中模型敏感度为44.7%(95% CI 40.0-50.0),特异度为85.3%(95% CI 83.4-87.0)。
  • 加拿大队列阳性似然比为3.03(95% CI 2.57-3.56),阴性似然比为0.65(95% CI 0.59-0.71)。
  • 构建受试者工作特征曲线后,加拿大队列最大阳性似然比达3.93。
  • 英国队列敏感度和特异度分别为52.5%(95% CI 42.2-62.7)和84.3%(95% CI 79.3-88.6)。
  • 英国队列阳性似然比为3.35(95% CI 2.38-4.70),阴性似然比为0.56(95% CI 0.45-0.68),最大阳性似然比为4.15。

关键数值与推荐

  • 加拿大队列模型敏感度44.7%(95% CI 40.0-50.0),特异度85.3%(95% CI 83.4-87.0),阳性似然比3.03(95% CI 2.57-3.56),阴性似然比0.65(95% CI 0.59-0.71),最大阳性似然比3.93。
  • 英国队列敏感度52.5%(95% CI 42.2-62.7),特异度84.3%(95% CI 79.3-88.6),阳性似然比3.35(95% CI 2.38-4.70),阴性似然比0.56(95% CI 0.45-0.68),最大阳性似然比4.15。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为该测试有通过加入乳糜泻血清学和粪便钙卫蛋白等临床标志物进行改进的潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The accuracy of symptom-based diagnostic criteria for irritable bowel syndrome (IBS) is modest. AIMS: To derive and validate a new test that utilises latent class analysis. METHODS: Symptom, colonoscopy, and histology data were collected from 1981 patients and 360 patients in two cohorts referred to secondary care for investigation of their gastrointestinal symptoms in Canada and the UK, respectively. Latent class analysis was used to identify naturally occurring clusters in patient-reported symptoms in the Canadian dataset, and the latent class model derived from this was then applied to the UK dataset in order to validate it. Sensitivity, specificity, and positive and negative likelihood ratios (LRs) were calculated for the latent class models. RESULTS: In the Canadian cohort, the model had a sensitivity of 44.7% (95% CI 40.0-50.0) and a specificity of 85.3% (95% CI 83.4-87.0). Positive and negative LRs were 3.03 (95% CI 2.57-3.56) and 0.65 (95% CI 0.59-0.71) respectively. A maximum positive LR of 3.93 was achieved following construction of a receiver operating characteristic curve. The performance in the UK cohort was similar, with a sensitivity and specificity of 52.5% (95% CI 42.2-62.7) and 84.3% (95% CI 79.3-88.6), respectively. Positive and negative LRs were 3.35 (95% CI 2.38-4.70) and 0.56 (95% CI 0.45-0.68), respectively, with a maximum positive LR of 4.15. CONCLUSIONS: A diagnostic test for IBS, utilising patient-reported symptoms incorporated into a latent class model, performs as accurately as symptom-based criteria. It has potential for improvement via addition of clinical markers, such as coeliac serology and faecal calprotectin.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sood R, Gracie DJ, Gold MJ, et al. Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Aliment Pharmacol Ther. 2017. PMID: 28105700. doi:10.1111/apt.13949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。